Future News: If You Have Money, Don’t Be In Trouble

Chapter 587: Yeli Pharmaceutical Resolutely Takes Countermeasures

"The lady."

He Jinqiu gave the first chance to ask a question to a western female reporter in her thirties with blonde hair and blue eyes.

The female reporter stood up, took the microphone handed over by the service staff, and said:

"Hello host, I am Emily, a reporter from the Three Letters News Agency. I would like to ask the host, whether the medical records and examination results of 100 volunteers released by Yeli Pharmaceuticals are suspected of leaking the personal privacy of the patients. If the privacy is leaked Does Yeri Pharmaceutical have a compensation plan for the inconvenience and troubles they have brought to their future lives?"

Because the public clinical trial has not yet started, she can't find any faults, so she finds faults in the procedures, which is the usual trick of the Three Letters News Agency.

He Jinqiu smiled contemptuously, and said: "I don't know what the purpose of your question is, you should know that when these one hundred volunteers submitted their application to Yeli Pharmaceutical, they had already signed to allow Yeli Pharmaceutical to report to the media and society. Publish the consent form for his illness, including but not limited to his past medical records and the results and conclusions of various examinations during this clinical trial."

"They were forced," Emily yelled.

"Have you asked the patient himself? Or did the patient's family tell you? Which patient's accompanying reporter are you?" He Jinqiu sternly reprimanded.

He then waved to nearby staff.

"Staff, check it out. If the patients or family members that this lady has come into contact with feel compelled, we respect their choice and remove them from the published medical information, but he will also lose the opportunity to participate in open clinical trials. , Obligations and opportunities are equal. The transportation and accommodation expenses of the patient, his family members and the accompanying reporter shall be implemented according to the agreement signed by both parties. The flower planter is a country ruled by law, and the agreement signed by both parties is protected by law. The reporter Ma'am, you may be satisfied with that."

There was an uproar in the hall.

The florist reporters in the audience applauded, it was so relieved.

These foreign reporters can't see the good of planting flowers.

The toughness of Yeli Pharmaceutical is also a manifestation of strength, and they have the confidence to say so.

Emily was dumbfounded, and she quickly explained: "The patients and family members who accompanied me never said anything like that."

The patient she followed was a well-known barrister in a beautiful country, and he was already terminally ill.

According to the conclusion given by a well-known domestic medical institution, lung cancer is already at an advanced stage with systemic metastasis, and his survival period will not exceed half a year.

die.

The barrister should not be in a hurry with her.

He Jinqiu said with a stern face: "Then the 'forced theory' you mentioned was fabricated by you? A hypothetical? If so, your purpose is obvious, that is to stop the disease that can save tens of thousands of cancer patients. The advent of special drugs? Right, whose interests are you representing? Is it the pharmaceutical companies that charge money from cancer patients if they don’t cure the disease?”

He Jinqiu's words can be described as heartbreaking, and put Emily on the opposite side of all cancer patients.

Emily sat back in her chair awkwardly, lowered her head and dared not speak.

At this time, a staff member came up from the backstage and whispered something in He Jinqiu's ear.

He Jinqiu nodded, and then said:

"We have ordered the staff to ask Mr. Thomas and his family members for opinions again. If this reporter lady said, we will terminate the agreement with Mr. Thomas. The entire inquiry process will be recorded and videotaped with Mr. Thomas' knowledge, so as to It will be used as legal evidence in the future, and before entering the ward tomorrow, Yeli Pharmaceuticals will once again confirm its true wishes to all volunteers, and will terminate the agreement for volunteers who feel compelled. The past medical records of the volunteers will be published at 8:00 am tomorrow."

The Thomas that He Jinqiu said was Emily's accompanying patient, a famous barrister.

There was another commotion in the venue.

Emily was ashamed and her face was as white as paper. She had a premonition that she would be accused by Thomas and his family.

Afterwards, He Jinqiu pointed at another reporter, "This gentleman."

A flower grower stood up and took the microphone, "Hello host, I am Zhu Yiming, a reporter from Fengjing Evening News. What I want to ask is, this clinical trial is only 5 days. If the patient is cured, what standard is used to determine whether the patient is cured? My question is over."

This reporter was arranged by Yeri Pharmaceuticals in advance.

He Jinqiu replied.

"This question is very good. Regarding the recovery standard, we completely follow the recovery guidance document published by the WHO, with the aid of imaging and laboratory results. This standard can be found on the official website of the WHO, and Yeri The pharmaceutical has also added a standard of our own on this basis, that is to say, if the volunteers who are diagnosed as cured after the end of the clinical trial relapse or suffer from any other cancer within the next year, we at Yeli Pharmaceuticals will abide by the recruitment criteria. Promise on announcement, pay volunteers 1

million dollars in compensation and continue to treat him free of charge. "

There was another commotion in the venue.

Experts from the WHO and other medical institutions sitting in the first row also expressed surprise.

You know, the last item He Jinqiu promised is extremely harsh.

Due to the differences in the environment and diet of the patients, there is a possibility of developing other cancers within a year, and the possibility is extremely high, because these volunteers themselves are prone to cancer or have a family genetic history.

He Jinqiu laughed, and after the noise subsided, he continued: "All the experts and journalist friends here can monitor our implementation, but the recurrence and other cancers I'm talking about here are not some individual Or the medical institution has the final say, it needs to go through full medical and judicial confirmation, including express confirmation from who.”

He Jinqiu paused for a few seconds and continued:

"Yeli Pharmaceuticals is not being taken advantage of, and will not be exploited by others. For those media and individuals who maliciously slander and frame Yeli Pharmaceuticals, Yeli Pharmaceuticals will resolutely fight back, for example, to be blacklisted by Yeri Pharmaceuticals. From now on, these people Including their spouses, descendants, and relatives are permanently prohibited from using all products of Yeli Pharmaceuticals. As for how Yeli Pharmaceuticals can fulfill its promises, we have our own methods, and journalists and friends will naturally understand after this clinical trial is over."

"Buzz..."

There was another uproar.

He Jinqiu's threatening words made the foreign journalists present, especially the Western journalists, feel a strong sense of malice, which was obviously aimed at them.

Who gave Yeli Pharmaceuticals such courage?

Liang Jingru?

In fact, He Jinqiu has a reason for saying this.

If the clinical trial of cancer prevention and control is successful, it will definitely touch the interests of some people, especially the western pharmaceutical groups. It is conceivable that they will use despicable and shameless methods to discredit Yeli Pharmaceuticals.

Some people or institutions may even take the risk and use some extreme methods on volunteers. Although it cannot stop the development of Yeli Pharmaceuticals, troubles cannot be avoided, and Yeli Pharmaceuticals has to guard against them.

After finishing speaking, He Jinqiu pointed to another Western reporter.

The reporter asked about Mr. Buffett's treatment.

He Jinqiu said: Mr. Buffett will attend the press conference at an appropriate time, but not now.

Subsequent questions revolve around the patient and the treatment script.

He Jinqiu answered them one by one.

At 20 o'clock, the first press conference of Yeli Pharmaceutical's open clinical trial ended.